Table of Contents
Chromatography Research International
Volume 2013, Article ID 432753, 5 pages
http://dx.doi.org/10.1155/2013/432753
Research Article

A Stability Indicating UPLC Method for the Determination of Levofloxacin Hemihydrate in Pharmaceutical Dosage Form: Application to Pharmaceutical Analysis

1Department of Chemistry, Saurashtra University, Rajkot-360 005, Gujarat, India
2Arts Commerce and Science College, Borsad 388540, Gujarat, India

Received 28 February 2013; Accepted 3 June 2013

Academic Editor: Antonio Martín-Esteban

Copyright © 2013 Batuk Dabhi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Kumar, A. Chitra, V. Amrithraj, and N. Kumar, “New RP-HPLC method development and validation for estimation of levofloxacin in tablet dosage form,” Journal of Global Trends in Pharmaceutical Sciences, vol. 2, no. 3, pp. 264–276, 2011. View at Google Scholar
  2. K. Kothekar, J. Balasundaram, A. Khandhar, and R. Mishra, “Quantitative determination of levofloxacin and ambroxol hydrochloride in pharmaceutical dosage form by reversed-phase high performance liquid chromatography,” Eurasian Journal of Analytical Chemistry, vol. 2, no. 1, 2007. View at Google Scholar
  3. T. Santhoshi, K. Kumar, V. Rao, and A. Ravipati, “Development and validation of RP-HPLC method for simultaneous estimation of levofloxacin and ornidazole in pharmaceutical dosage form,” Journal of Pharmacy Research, vol. 4, no. 11, p. 3864, 2011. View at Google Scholar
  4. N. S. Lakka and N. Goswami, “A novel isocratic RP-HPLC method development and validation for estimation of 5HMF in Levofloxacin Hemihydrate intravenous infusion,” International Journal of Research in Pharmaceutical Sciences, vol. 2, no. 1, pp. 45–51, 2011. View at Google Scholar · View at Scopus
  5. U. Neckel, C. Joukhadar, M. Frossard, W. Jäger, M. Müller, and B. X. Mayer, “Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography,” Analytica Chimica Acta, vol. 463, no. 2, pp. 199–206, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Mehta, Y. Pancholi, V. Patel, N. Kshatri, and N. Vyas, “Development and validation of a sensitive stability indicating method for quantification of levofloxacin related substances and degradation products in pharmaceutical dosage form,” International Journal of PharmTech Research, vol. 2, no. 3, pp. 1932–1942, 2010. View at Google Scholar · View at Scopus
  7. N. W. Sheikh, A. S. Tripathi, V. Chitra, A. Choudhury, and A. P. Dewani, “Development and validation of RP-HPLC assay for levofloxacin in rat plasma and saliva: application to pharmacokinetic studies,” African Journal of Pharmacy and Pharmacology, vol. 5, no. 13, pp. 1612–1618, 2011. View at Google Scholar · View at Scopus
  8. S. Rahar, S. Dogra, D. Panchru, P. Singh, and G. Shah, “Development and validation of UV-visible spectroscopic method for the estimation of levofloxacin hemihydrate in bulk and marketed formulation,” International Journal of Institutional Pharmacy and Life Sciences, vol. 1, no. 2, 2011. View at Google Scholar
  9. A. A. Shirkhedkar and S. J. Surana, “Quantitative determination of levofloxacin hemihydrate in bulk and tablets by UV-spectrophotometry and first order derivative methods,” Pakistan Journal of Pharmaceutical Sciences, vol. 22, no. 3, pp. 301–302, 2009. View at Google Scholar · View at Scopus
  10. V. N. Desai, O. E. Afieroho, B. O. Dagunduro, T. J. Okonkwo, and C. C. Ndu, “A simple UV spectrophotometric method for the determination of levofloxacin in dosage formulations,” Tropical Journal of Pharmaceutical Research, vol. 10, no. 1, pp. 75–79, 2011. View at Google Scholar · View at Scopus
  11. FDA, ICH-Q1A (R2): Stability Testing of New Drug Substances and Products, vol. 68, U S Food and Drug Administration, Washington, DC, USA, 2nd edition, 2003.
  12. FDA, ICH-Q1B: Photo-Stability Testing of New Drug Sub-Stances and Products, vol. 62, U S Food and Drug Administration, Washington, DC, USA, 1997.
  13. FDA, ICH-Q2 (R1): Validation of Analytical Procedures: Text and Methodology, vol. 60, U S Food and Drug Administration, Washington, DC, USA, 1995.
  14. United State Pharmacopoeia, The U.S. Pharmacopeia Convention, United State Pharmacopoeia, Rockville, Md, USA, 30th edition, 2007.